期刊文献+

Ⅱ型食管胃结合部腺癌手术径路的合理选择探讨 被引量:3

Reasonable selection of operative approach of type Ⅱ adenocarcinoma of the esophagogastric junction
下载PDF
导出
摘要 目的:探讨Ⅱ型食管胃结合部腺癌手术的合理径路。方法:回顾性分析168例接受手术治疗的Ⅱ型AEG患者的临床资料,根据手术径路的不同分为经胸径路(Transthoracic approach,TT)组和经腹食管裂孔切开径路(abdominal transhiatal approach,TH)组,分析这2种手术径路与疗效之间的关系,判定各径路的优劣。结果:两组在切缘癌残留率、5年生存率、吻合口瘘和吻合口狭窄发生率方面,差异均无统计学意义(P>0.05),而在平均清扫淋巴结数目及减少心肺并发症发生率、手术时间、术后平均住院时间方面,经腹食管裂孔切开径路组要明显优于经胸径路组,差异有统计学意义(P<0.05)。结论:经腹食管裂孔切开径路手术兼具经腹和经胸手术的优点,手术效果良好,并发症少,是Ⅱ型AEG的首选手术径路。 Objective:To investigate the reasonable operative approach of type Ⅱ adenocarcinoma of the esophagogastric junction(AEG).Methods:The clinical data of 168 patients of type Ⅱ AEG accepted operation were analyzed retrospectively.According to different operative approach,the patients were divided into two groups:transthoracic(TT)approach group and abdominal transhiatal(TH)approach group.The relationship between two operative approaches and curative effect were analyzed to determine a better approach.Results:No significant difference(P0.05)were observed in the residual incision margin cancer rate,5-year survival rate,anastomotic leakage rate and anastomotic stricture rate of the two surgical approaches.However,the significant difference(P0.05)was observed in the average number of harvested lymph nodes,the reduction of cardiopulmonary complication rate,the length of operation time and hospital stay after operation of two surgical approaches,TH group was better than TT group.Conclusion:Abdominal transhiatal approach is preferred operative approach of type Ⅱ AEG which has a good effectiveness of operation,fewer complications and the advantages of both transabdominal and transthoracic operations.
出处 《现代肿瘤医学》 CAS 2013年第7期1555-1557,共3页 Journal of Modern Oncology
关键词 食管胃结合部腺癌 手术径路 经腹食管裂孔切开径路 adenocarcinoma of the esophagogastric junction operative approach abdominal transhiatal approach
  • 相关文献

参考文献13

  • 1Siewert JR, Holscher AH, Becker K, et al. Cardiacancer: therapeuti- cally relevant classification[ J]. Chirurg, 1987,58 ( 1 ) :25 - 32.
  • 2Botterweck AA, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten Euro- pean countries [ J ]. Int J Epidemiol,2000,29:645 - 654.
  • 3章宏,厉有名,王伟.食管腺癌临床流行病学研究[J].中华消化杂志,2003,23(11):696-697. 被引量:24
  • 4胡祥.食管胃结合部腺癌浸润转移方式和临床特征[J].中国实用外科杂志,2012,32(4):280-283. 被引量:7
  • 5Siewert JR, Feith M, Wemer M, et al. Adenocarcinoma of the esophagogastric junction : results of surgical therapy based on ana- tomicaL/topographic classification in 1002 consecutive patients [J]. Ann Surg,2000,232(2) :353 -361.
  • 6Yamashita H, Katai H, Morita S, et al. Optimal extent of lymphnode dissection for Siewert type II esophagogastric junction carcinoma [ J ]. Ann Surg,2011,254 (2) :274 - 280.
  • 7Pedrazzani C, de Manzoni G, Marrelli D, et al. Lymph node involve- ment in advanced gastroesophageal junction adenocarcinoma [ J ]. J Thorac Cardiovasc Surg,2007,134 (2) : 378 - 385.
  • 8Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gas- troesophageal junction : influence of esophageal resection margin and operative approach on outcome [ J ]. Ann Surg, 2007,246 ( 1 ) : 1 - 8.
  • 9Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal ap- proach venus abdominal transhiatal approach for gastric cancer of the cardia or subcardia : a randomized controlled ltria [ J ]. Lancet Oncol,2006,7 ( 8 ) :644 - 651.
  • 10张常华,何裕隆,詹文华,陈创奇,蔡世荣,黄美近.贲门癌根治术后患者预后的多因素分析[J].中华胃肠外科杂志,2006,9(6):483-487. 被引量:18

二级参考文献36

  • 1赵广法,师英强,傅红,蔡三军,王亚农,莫善兢.贲门癌手术的理想途径—经左胸腹联合斜切口[J].外科理论与实践,2004,9(6):494-498. 被引量:10
  • 2李延光,周骏.经腹应用吻合器治疗胃底贲门癌24例体会[J].临床外科杂志,2006,14(8):530-531. 被引量:1
  • 3赵刚,吴志勇,卞正乾,孙勇伟,罗蒙,陈炜,顾磊.贲门癌选择胸腹联合切口的标准[J].上海交通大学学报(医学版),2006,26(8):845-848. 被引量:19
  • 4张常华,何裕隆,詹文华,陈创奇,蔡世荣,黄美近.贲门癌根治术后患者预后的多因素分析[J].中华胃肠外科杂志,2006,9(6):483-487. 被引量:18
  • 5Parkin D,Pisani P,Ferley J.et al.Global cancer statistics[J].CA Cancer J Clin,1999,49:33-64.
  • 6Pompiliu P,Uwe W,Hauke L,et al.Proximal versus distal gastric carcinoma-what are the differences?[J].Ann Surg Oncol,2000,7(7):520-525.
  • 7Tytgat GN,Bartelink H,Bernards R,et al.Cancer of the esophagus and gastric cardia:recent advances[J].Dis Esophagus,2004,17:10-26.
  • 8Fein M,Fuchs KH,Ritter M,et al.Application of the new classification for cancer of the cardia[J].Surgery,1998,124:707-713.
  • 9Siewert JR,Feith M,Stein HJ.Biologic and clinical variations of aclenocarcinoma at the esophago-gastric junction:relevance of a topographic-anatomic subclassification[J].J Surg Oncol,2005,90:139-146.
  • 10Bai JG,Lv Y,Dang CX.Adenocarcinoma of the esophagogastric junction in China according to Siewert's classification[J].Jpn J Clin Oncol,2006,36(6):364-367.

共引文献84

同被引文献53

  • 1钱锋,孙刚,唐波,王自强,石彦,赵永亮,罗华星,余佩武.腹腔镜胃癌根治手术的学习曲线[J].中国微创外科杂志,2008,8(6):510-512. 被引量:46
  • 2Holscher A H,Siewert J R. Classification of adenocarcinomas of the esophagogastric junction[M].40128 Bologna:Monduzzi Editore,1996.1-2.
  • 3Siewert JR,Feith M. Adenocarcinoma of the esophagogastric junction:competition between Barrett and gastric cancer[J].{H}Journal of the American College of Surgeons,2007,(4 Suppl):S49-S53.
  • 4日本胃癌学会.胃癌取扱い规约[M]东京:金原出版株式会社,20102-18.
  • 5Rice TW,Rusch VW,Ishwaran H. Cancer of the esophagus and esophagogastric junction:data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals[J].{H}CANCER,2010,(16):3763-3773.
  • 6Bhurgri Y,Pervez S,Kayani N. Rising Incidence of Gastric Malignancies in Karachi,1995-2002[J].Asian Paci J Cancer Prey,2009,(1):41-44.
  • 7Siewert JR,Feith M,Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction:Relevance of a topographic-anatomic subclassification[J].{H}Journal of Surgical Oncology,2005,(3):139-146.
  • 8Walther C,Zilling T,Perfekt R. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction:a study of the Swedish population between 1970 and 1997[J].{H}European Journal of surgery,2001,(10):748-757.
  • 9Pohl H,Sirovich B,Welch HG. Esophageal adenocarcinoma incidence:are we reaching the peak[J].{H}Cancer Epidemiology Biomarkers & Prevention,2010,(6):1468-1470.
  • 10Wang K,Yang CQ,Duan LP. Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years:experience at a large tertiary medical center in China[J].{H}TUMORI,2012,(5):568-574.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部